Unavets | AI Transformation Index
Unavets is a structurally durable business precisely because the thing it sells — physical veterinary care — is not amenable to AI substitution; the regula...

Overview
Unavets operates a network of 90+ veterinary clinics and hospitals across Spain and Portugal, generating revenue through fee-for-service clinical care including diagnostics, surgery, emergency medicine, and preventive services for companion animals.
Executive Summary
Unavets is a structurally durable business precisely because the thing it sells — physical veterinary care — is not amenable to AI substitution; the regulatory, physical, and clinical barriers are genuine and multilayered. The AI opportunity is real but modest in scale: efficiency gains in documentation, diagnostics support, and back-office operations can improve margins and veterinarian productivity, but they will not redefine the business model or dramatically expand throughput. For a PE investor, this is a durable physical-services asset with incremental AI upside rather than a transformative AI opportunity — the investment thesis rests on market consolidation, geographic expansion, and operational leverage rather than AI-driven step-change value creation.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
56.1
Ciridae AI Score
Durability Rationale
Unavets' durability is anchored in the irreducibly physical nature of veterinary care delivery — surgery, emergency medicine, and hands-on treatment cannot be replicated by AI, making the core paid outcome structurally resilient. Layered on top of this physical moat are meaningful regulatory barriers (licensed professionals, clinic registration) and a capital-intensive physical footprint that AI-native entrants cannot circumvent with software. The primary durability vulnerability is the relatively moderate switching cost at the individual clinic level and limited differentiation versus other consolidator platforms, which could allow a well-capitalized competitor to replicate the model — but this is a competitive dynamics risk, not an AI substitution risk.
Opportunity Rationale
The AI opportunity for Unavets is real but structurally bounded by the physical nature of veterinary care — the business's core activity simply cannot be automated at scale. The most compelling opportunity lies in reducing veterinarian administrative burden (clinical documentation, imaging interpretation support), improving scheduling and client communications, and leveraging network-wide clinical data to improve diagnostic protocols across clinics. These are meaningful operational efficiency gains, but they do not represent a step-change transformation because the throughput constraint is physical capacity and licensed professional supply, not cognitive processing bandwidth.
Key Risks
Telehealth and AI-enabled remote triage platforms could siphon lower-acuity consultations (the highest-volume, lowest-complexity cases) faster than expected, reducing foot traffic and revenue per clinic while leaving only the higher-complexity, lower-margin emergency and surgical cases for the physical network.
The AI opportunity assessment could be too conservative if AI-assisted diagnostics (particularly imaging AI in radiology and pathology) advances faster than expected, allowing significantly higher veterinarian throughput and fundamentally changing the economics of the clinical model — making the transformation upside larger than the physical constraint thesis implies.
Company Overview
| Headquarters | Madrid, Community of Madrid, Spain |
| Products / Services | Veterinary healthcare services including emergency care, general medicine, surgery, diagnostic imaging, and other veterinary medical services. |
| Deal Partners | Karim Khairallah |
PE / Ownership History
| Event | Details |
|---|---|
Sale Process Launch Announcement Early February 2024 | Oaktree Capital Management, owner of UNAVETS, was reported to be launching a sale process for UNAVETS. The company had generated around EUR 15 million EBITDA in the prior year, with a valuation range between EUR 200 million and EUR 250 million. Jefferies was awarded the sale mandate. [ION Analytics](https://ionanalytics.com/insights/mergermarket/unavets-sale-process-set-to-launch-sources) |
Acquisition of Irubide Clinic July 2023 | UNAVETS, backed by Oaktree Capital Management, acquired the Irubide Clinic in Vitoria-Gasteiz, Spain. The clinic offers a range of veterinary services and joined the UNAVETS network as part of its growth strategy. [Capital-Riesgo](https://capital-riesgo.es/en/articles/unavets-backed-by-oaktree-capital-announces-the-acquisition-of-irubide-clinic) |
Financing from Ares Management November 18, 2022 | UNAVETS raised 116 million from Ares Management Credit funds to support growth, refinance existing debt, and fund acquisitions. At this time, UNAVETS was majority owned by funds managed by Oaktree Capital Management L.P. The financing was aimed at expanding veterinary hospitals and clinics and investing in related areas. [PR Newswire](https://www.prnewswire.com/news-releases/unavets-receives-116-million-financing-from-ares-management-to-support-growth-301682791.html) |
Executives
| Name | Background |
|---|---|
Enrique Cardona CEO | Enrique Cardona has over 25 years of experience in both human and veterinary healthcare sectors. Before joining the veterinary sector, he held senior management roles in the human health hospital sector, including nursing home business development and as head of international markets for a US multinational company specializing in second opinion healthcare and telemedicine. He was previously CEO of Vetsum for nearly 5 years, Director General at Best Doctors for over 4 years, and COO at CASER for 2 years. He is based in Algete, Community of Madrid, Spain, and educated at Universidad Politécnica de Valencia. His extensive experience in human health has been instrumental in his contributions to veterinary healthcare at Unavets [Unavets Our Team](https://www.unavets.com/our-team), [LinkedIn](https://es.linkedin.com/in/enriquecardonagarcia/es). |
Guilherme Assis Associate CEO and CFO | Guilherme Assis has over 25 years of experience in finance and executive roles across multiple sectors globally, including India, Singapore, and Brazil. He has held leadership roles at multinational companies such as Consoveyo, S.A. (CFO), Efacec Group (CFO, Director, Country Manager), and Onevet Group (Managing Director and Country Manager). His expertise includes optimizing global finance and treasury teams, management systems, operations, restructuring, and business turnaround. He is also a board member of Onevet. He studied at IESE Business School and is based in Portugal [Unavets Our Team](https://www.unavets.com/our-team), [LinkedIn](https://pt.linkedin.com/in/guilherme-assis-739954a). |
Ignacio González Head of Merger and Acquisitions | Ignacio leads Unavets' significant M&A activities. He is a founding partner of Trusteam Capital and managing partner of UNOMASDOS, providing business advisory services. He has over 20 years of financial sector experience including at La Caixa and multinational companies in the food and communications sectors [Unavets Our Team](https://www.unavets.com/our-team). |
Aarón Filiberto Sisternes Finance Advisor | Economist with 20+ years of experience, including management roles at Eastman Kodak. He serves on boards of companies in multiple countries and specializes in economic-financial management, outsourcing, restructuring, M&A, and new business models [Unavets Our Team](https://www.unavets.com/our-team). |
Oaktree Capital Management